Comparative analysis of lipotoxicity induced by endocrine, pharmacological, and innate immune stimuli in rat basophilic leukemia cells

Journal of Immunotoxicology

Volumn 12, Issue 4, 2015, Pages 385-394

  Maaetoft Udsen, Kristina ^a   Greineisen, William E ^a,b   Aldan, Johnny Tudela ^a   Magaoay, Hazelle ^a   Ligohr, Cheryll ^a   Shimoda, Lori M N ^a   Sung, Carl ^a   Turner, Helen ^a,b  

^a CHAMINADE UNIVERSITY OF HONOLULU   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

Lipotoxicity; mast cells; phospholipidosis; steatosis

Indexed keywords

CHLORCYCLIZINE; CHLOROQUINE; CYCLOSPORIN A; INSULIN; PARACETAMOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROPRANOLOL; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; FAT DROPLET; PHOSPHOLIPID; TLR2 PROTEIN, RAT; TLR4 PROTEIN, RAT; TUMOR PROTEIN;

ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; LEUKEMIA CELL; LIPID STORAGE; LIPIDOSIS; LIPOTOXICITY; MAST CELL LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; STEATOSIS; UPREGULATION; ANIMAL; GENE EXPRESSION REGULATION; IMMUNOLOGY; INNATE IMMUNITY; MAST CELL; PATHOLOGY; TUMOR CELL LINE;

RATTUS;

ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, LEUKEMIC; IMMUNITY, INNATE; LEUKEMIA, BASOPHILIC, ACUTE; LIPID DROPLETS; MAST CELLS; NEOPLASM PROTEINS; PHOSPHOLIPIDS; PPAR GAMMA; RATS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84938882757     PISSN: 1547691X     EISSN: 15476901     Source Type: Journal    
DOI: 10.3109/1547691X.2014.990655     Document Type: Article

References (35)

1. 2 activity. Anal. Biochem. 434:78-83.
2. Anderson, N., and Borlak, J. 2006. Drug-induced phospholipidosis. FEBS Lett. 580:5533-5540.
3. Bagatolli, L. A., Parasassi, T., and Gratton, E. 2000. Giant phospholipid vesicles: Comparison among the whole lipid sample characteristics using different preparation methods: A two photon fluorescence microscopy study. Chem. Phys. Lipids 105:135-147.
4. Begriche, K., Massart, J., Robin, M. A., et al. 2011. Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver. J. Hepatology 54:773-794.
5. Bozza, P. T., Bakker-Abreu, I., Navarro-Xavier, R. A., and Bandeira-Melo, C. 2011. Lipid body function in eicosanoid synthesis: An update. Prostagl. Leukot. Essent. Fatty Acids 85:205-213.
6. Bozza, P. T., Magalhaes, K. G., and Weller, P. F. 2009. Leukocyte lipid bodies - Biogenesis and functions in inflammation. Biochim. Biophys. Acta 1791:540-551.
7. Bozza, P. T., Melo, R. C., and Bandeira-Melo, C. 2007. Leukocyte lipid bodies regulation and function: Contribution to allergy and host defense. Pharmacol. Ther. 113:30-49.
8. D'Avila, H., Melo, R. C., Parreira, G. G., et al. 2006. Mycobacterium bovis bacillus Calmette-Guerin induces TLR2-mediated formation of lipid bodies: Intracellular domains for eicosanoid synthesis in vivo. J. Immunol. 176:3087-3097.
9. Dvorak, A. M., Dvorak, H. F., Peters, S. P., et al. 1983. Lipid bodies: Cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells. J. Immunol. 131:2965-2976.
10. Dvorak, A. M., Hammel, I., Schulman, E. S., et al. 1984. Differences in the behavior of cyto-plasmic granules and lipid bodies during human lung mast cell degranulation. J. Cell Biol. 99:1678-1687.
11. Dvorak, A. M., Morgan, E., Schleimer, R. P., et al. 1992. Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclo-oxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, Type II pneumocytes, and neutrophils. J. Histochem. Cytochem. 40:759-769.
12. Greineisen, W. E., Shimoda, L. M., Maaetoft-Udsen, K., and Turner, H. 2012. Insulin-containing lipogenic stimuli suppress mast cell degranulation potential and up-regulate lipid body biogenesis and eicosanoid secretion in a PPAR-independent manner. J. Leukocyte Biol. 92:653-665.
13. Halliwell, W. H. 1997. Cationic amphiphilic drug-induced phospholipidosis. Toxicol. Pathol. 25:53-60.
14. Heyneman, C. A., and Reasor, M. J. 1986. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. II. Drug uptake into cells in vitro. J. Pharmacol. Exp. Ther. 236:60-64.
15. Johnson, M. M., Vaughn, B., Triggiani, M., et al. 1999. Role of arachidonyl triglycerides within lipid bodies in eicosanoid formation by human poly-morphonuclear cells. Am. J. Respir. Cell Mol. Biol. 21:253-258.
16. Krasnowska, E. K., Gratton, E., and Parasassi, T. 1998. Prodan as a membrane surface fluorescence probe: Partitioning between water and phospholipid phases. Biophys. J. 74:1984-1993.
17. Krilov, D., Balarin, M., Kosovic, M., and Brnjas-Kraljevic, J. 2008. Location of PRODAN in lipid layer of HDL particle: A Raman study. Eur. Biophys. J. 37:1105-1110.
18. Maeyama, K., Emi, M., and Tachibana, M. 2005. Nuclear receptors as targets for drug development: Peroxisome proliferator-activated receptor gamma in mast cells: Its roles in proliferation and differentiation. J. Pharm. Sci. 97:190-194.
19. Marshall, J. S., McCurdy, J. D., and Olynych, T. 2003. Toll-like receptormediated activation of mast cells: Implications for allergic disease? Int. Arch. Allergy Immunol. 132:87-97.
20. Mattos, K. A., D'Avila, H., Rodrigues, L. S., et al. 2010. Lipid droplet formation in leprosy: Toll-like receptor-regulated organelles involved in eicosanoid formation and Mycobacterium leprae pathogenesis. J. Leukocyte Biol. 87:371-384.
21. Melo, R. C., D'Avila, H., Fabrino, D. L., et al. 2003. Macrophage lipid body induction by Chagas disease in vivo: Putative intracellular domains for eicosanoid formation during infection. Tissue Cell 35:59-67.
22. Melo, R. C., D'Avila, H., Wan, H. C., et al. 2011. Lipid bodies in inflammatory cells: Structure, function, and current imaging techniques. J. Histo-chem. Cytochem. 59:540-556.
23. Melo, R. C., Paganoti, G. F., Dvorak, A. M., and Weller, P. F. 2013. The internal architecture of leukocyte lipid body organelles captured by three-dimensional electron microscopy tomography. PLoS One 8:e59578.
24. Muehlbacher, M., Tripal, P., Roas, F., and Kornhuber, J. 2012. Identification of drugs inducing phospholipidosis by novel in vitro data. Chemmedchem 7:1925-1934.
25. Pacheco, P., Bozza, F. A., Gomes, R. N., et al. 2002. Lipopolysaccharideinduced leukocyte lipid body formation in vivo: Innate immunity elicited intracellular loci involved in eicosanoid metabolism. J. Immunol. 169:6498-6506.
26. Park, S., Choi, Y. J., and Lee, B. H. 2012. In vitro validation of drug-induced phospholipidosis. J. Toxicol. Sci. 37:261-267.
27. Passante, E., and Frankish, N. 2009. The RBL-2H3 cell line: Its provenance and suitability as a model for the mast cell. Inflamm. Res. 58:737-745.
28. Ranall, M. V., Gabrielli, B. G., and Gonda, T. J. 2011. High-content imaging of neutral lipid droplets with 1,6-diphenylhexatriene. Biotechniques 51:35-36, 38-42.
29. Reasor, M. J., Heyneman, C. A., and Walker, E. R. 1982. Chlorcyclizine-induced pulmonary phospholipidosis in rats. Res. Commun. Chem. Pathol. Pharmacol. 38:235-246.
30. Shayman, J. A., and Abe, A. 2013. Drug induced phospholipidosis: An acquired lysosomal storage disorder. Biochim. Biophys. Acta 1831:602-611.
31. Silva, A. R., Pacheco, P., Vieira-de-Abreu, A., et al. 2009. Lipid bodies in oxidized LDL-induced foam cells are leukotriene-synthesizing organelles: A MCP-1/CCL2 regulated phenomenon. Biochim. Biophys. Acta 1791:1066-1075.
32. Song, M., Kim, Y. J., and Ryu, J. C. 2011. Phospholipidosis induced by PPARγ signaling in human bronchial epithelial (BEAS-2B) cells exposed to amiodarone. Toxicol. Sci. 120:98-108.
33. Storey, S. M., McIntosh, A. L., Senthivinayagam, S., et al. 2011. The phospholipid monolayer associated with perilipin-enriched lipid droplets is a highly organized rigid membrane structure. Am. J. Physiol. 301:E991-E1003.
34. Walther, T. C., and Farese Jr. R. V. 2009. The life of lipid droplets. Biochim. Biophys. Acta 1791:459-466.
35. Weller, P. F., Ackerman, S. J., Nicholson-Weller, A., and Dvorak, A. M. 1989. Cytoplasmic lipid bodies of human neutrophilic leukocytes. Am. J. Pathol. 135:947-959.